Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 7302965, 9 pages
https://doi.org/10.1155/2017/7302965
Research Article

Antidiabetic Effect of Tibetan Medicine Tang-Kang-Fu-San on High-Fat Diet and Streptozotocin-Induced Type 2 Diabetic Rats

1College of Basic Medicine, Hubei University of Chinese Medicine, Wuhan 430065, China
2College of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan 430074, China
3Center for the Study of Itch, Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO 63110, USA
4Barnes-Jewish Hospital, St. Louis, MO 63110, USA
5College of Nursing & Medical Technology, Jianghan University, Wuhan 430056, China
6Department of Encephalopathy, Wuhan Hospital of Traditional Chinese Medicine, Wuhan 430014, China

Correspondence should be addressed to Tiexiang Gao; moc.361@oaggnaixeit and Zhinan Mei; moc.361@nanihziem

Received 5 April 2017; Accepted 13 July 2017; Published 17 August 2017

Academic Editor: Dolores García Giménez

Copyright © 2017 Bailu Duan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. D. Rochester and O. Akiyode, “Novel and emerging diabetes mellitus drug therapies for the type 2 diabetes patient,” World Journal of Diabetes, vol. 5, no. 3, pp. 305–315, 2014. View at Publisher · View at Google Scholar
  2. Y. Saisho, “β-cell dysfunction: its critical role in prevention and management of type 2 diabetes,” World Journal of Diabetes, vol. 6, no. 1, pp. 109–124, 2015. View at Publisher · View at Google Scholar
  3. A. Chaudhury, C. Duvoor, V. S. Reddy Dendi et al., “Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management,” Frontiers in Endocrinology, vol. 8, article no. 6, 2017. View at Publisher · View at Google Scholar
  4. J. J. Marín-Peñalver, I. Martín-Timón, C. Sevillano-Collantes, and F. J. DelCañizo-Gómez, “Update on the treatment of type 2 diabetes mellitus,” World Journal of Diabetes, vol. 7, no. 17, pp. 354–395, 2016. View at Publisher · View at Google Scholar
  5. M. Ruscica, L. Baldessin, D. Boccia, G. Racagni, and N. Mitro, “Non-insulin anti-diabetic drugs: an update on pharmacological interactions,” Pharmacological Research, vol. 115, pp. 14–24, 2017. View at Publisher · View at Google Scholar
  6. K. Srinivasan and P. Ramarao, “Animal models in type 2 diabetes research: an overview,” Indian Journal of Medical Research, vol. 125, no. 3, pp. 451–472, 2007. View at Google Scholar · View at Scopus
  7. S. Skovsø, “Modeling type 2 diabetes in rats using high fat diet and streptozotocin,” Journal of Diabetes Investigation, vol. 5, no. 4, pp. 349–358, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Wang, J. Wang, and P. Chan, “Treating type 2 diabetes mellitus with traditional chinese and indian medicinal herbs,” Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 343594, 17 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Pang, Q. Zhou, T.-Y. Zhao et al., “Innovative thoughts on treating diabetes from the perspective of traditional chinese medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 905432, 12 pages, 2015. View at Publisher · View at Google Scholar
  10. J. He, X. Wu, Y. Kuang, T. Wang, K. Bi, and Q. Li, “Quality assessment of Chrysanthemum indicum Flower by simultaneous quantification of six major ingredients using a single reference standard combined with HPLC fingerprint analysis,” Asian Journal of Pharmaceutical Sciences, vol. 11, no. 2, pp. 265–272, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. D.-Q. Tang, X.-X. Zheng, X. Chen, D.-Z. Yang, and Q. Du, “Quantitative and qualitative analysis of common peaks in chemical fingerprint of Yuanhu Zhitong tablet by HPLC-DAD-MS/MS,” Journal of Pharmaceutical Analysis, vol. 4, no. 2, pp. 96–106, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Zheng, G. Shu, Z. Yang, S. Mo, Y. Zhao, and Z. Mei, “Antidiabetic effect of total saponins from Entada phaseoloides (L.) Merr. in type 2 diabetic rats,” Journal of Ethnopharmacology, vol. 139, no. 3, pp. 814–821, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Wang, T. Li, and P. Han, “The effect of tianmai xiaoke pian on insulin resistance through PI3-K/AKT signal pathway,” Journal of Diabetes Research, vol. 2016, Article ID 9261259, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Li, M. R. van der Sijde, S. J. L. Bakker et al., “Pleiotropic effects of lipid genes on plasma glucose, HbA1c, and HOMA-IR levels,” Diabetes, vol. 63, no. 9, pp. 3149–3158, 2014. View at Publisher · View at Google Scholar
  15. Z. Yang, X. Chen, Y. Chen, and Q. Zhao, “PGC-1 mediates the regulation of metformin in muscle irisinexpression and function,” American Journal of Translational Research, vol. 7, no. 10, pp. 1850–1859, 2015. View at Google Scholar
  16. C. Triplitt, C. Solis-Herrera, C. Reasner, R. A. DeFronzo, and E. Cersosimo, Classification of Diabetes Mellitus, MDText.com, Inc, South Dartmouth, Mass, USA, 2000–2015.
  17. K. Srinivasan, B. Viswanad, L. Asrat, C. L. Kaul, and P. Ramarao, “Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening,” Pharmacological Research, vol. 52, no. 4, pp. 313–320, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. P. J. Antony, G. R. Gandhi, A. Stalin et al., “Myoinositol ameliorates high-fat diet and streptozotocin-induced diabetes in rats through promoting insulin receptor signaling,” Biomedicine & Pharmacotherapy, vol. 88, pp. 1098–1113, 2017. View at Publisher · View at Google Scholar
  19. T. H. W. Huang, G. Peng, B. P. Kota et al., “Anti-diabetic action of Punica granatum flower extract: activation of PPAR-γ and identification of an active component,” Toxicology and Applied Pharmacology, vol. 207, no. 2, pp. 160–169, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Banihani, S. Swedan, and Z. Alguraan, “Pomegranate and type 2 diabetes,” Nutrition Research, vol. 33, no. 5, pp. 341–348, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. V. O. Gutierres, M. L. Campos, C. A. Arcaro et al., “Curcumin Pharmacokinetic and Pharmacodynamic Evidences in Streptozotocin-Diabetic Rats Support the Antidiabetic Activity to Be via Metabolite(s),” Evidence-based Complementary and Alternative Medicine, vol. 2015, Article ID 678218, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Ghosh, S. Banerjee, and P. C. Sil, “The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: a recent update,” Food and Chemical Toxicology, vol. 83, pp. 111–124, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Karuppagounder, S. Arumugam, V. V. Giridharan et al., “Tiny molecule, big power: multi-target approach for curcumin in diabetic cardiomyopathy,” Nutrition, vol. 34, pp. 47–54, 2017. View at Publisher · View at Google Scholar
  24. M. Hou, N. Venier, L. Sugar et al., “Protective effect of metformin in CD1 mice placed on a high carbohydrate-high fat diet,” Biochemical and Biophysical Research Communications, vol. 397, no. 3, pp. 537–542, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Matsui, Y. Hirasawa, T. Sugiura, T. Toyoshi, K. Kyuki, and M. Ito, “Metformin reduces body weight gain and improves glucose intolerance in high-fat diet-fed C57BL/6J Mice,” Biological and Pharmaceutical Bulletin, vol. 33, no. 6, pp. 963–970, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Vaag and S. S. Lund, “Non-obese patients with type 2 diabetes and prediabetic subjects: Distinct phenotypes requiring special diabetes treatment and (or) prevention?” Applied Physiology, Nutrition and Metabolism, vol. 32, no. 5, pp. 912–920, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Korkmaz-Icöz, S. Al Said, T. Radovits et al., “Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: Activation of the Akt pathway,” Cardiovascular Diabetology, vol. 15, no. 1, article no. 75, pp. 1–16, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Li, F. Wang, M. Xu, P. Howles, and P. Tso, “ApoA-IV improves insulin sensitivity and glucose uptake in mouse adipocytes via PI3K-Akt Signaling,” Scientific Reports, vol. 7, Article ID 41289, 2017. View at Publisher · View at Google Scholar
  29. M. I. Qadir, S. T. Naqvi, and S. A. Muhammad, “Curcumin: a polyphenol with molecular targets for cancer control,” Asian Pacific Journal of Cancer Prevention, vol. 17, no. 6, pp. 2735–2739, 2016. View at Google Scholar · View at Scopus